01 6GLAXO GRP LTD
01 611116721
01 6Blank
01 6Y
01 62029-02-26
Patent Expiration Date : 2029-02-26
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 11116721
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1691
Delist Requested :
Patent Use Description : INDICATED FOR THE ONCE...
Patent Expiration Date : 2029-02-26
Patent Expiration Date : 2029-02-26
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 11116721
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-3623
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-02-26
Patent Expiration Date : 2029-02-26
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 11116721
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-3623
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-02-26
Patent Expiration Date : 2029-02-26
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 11116721
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-3623
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-02-26
Patent Expiration Date : 2029-02-26
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 11116721
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1691
Delist Requested :
Patent Use Description : INDICATED FOR THE ONCE...
Patent Expiration Date : 2029-02-26
Patent Expiration Date : 2029-02-26
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 11116721
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1401
Delist Requested :
Patent Use Description : INDICATED FOR LONG-TER...
Patent Expiration Date : 2029-02-26
